EDTA PROCEEDINGS

 

 

 

 

 

VOLUME 18

 

 

 

 

 

PARIS - 1981

 

 

 

 

 

 

 

 

 

 

INTRODUCTION

 

 

 

 

 

Cover [PDF]

 

 

 

 

 

Preface [PDF]

 

 

 

 

 

Contents [PDF]

 

 

 

 

 

 

 

 

Part I – STATISTICAL REPORTS

Page

 

 

 

 

Combined Report on Regular Dialysis and Transplantation in Europe, XI, 1980   [PDF]

 

 

C Jacobs, M Broyer, F P Brunner, H Brynger, R A Donckerwolcke, P Kramer, N H Selwood, A J Wing, P H Blake

 

 

 

 

 

 

Combined Report on Regular Dialysis and Transplantation of Children in Europe, 1980  [PDF]

59

 

 

M Broyer, RA Doncherwolche, FP Brunner, H Brynger, C Jacobs, P Kramer, NH Selwood, AJ Wing, P H Blake

 

 

       

Part II – GUEST LECTURE

 

 

 

 

 

 

A review of seven years' home perotoneal dialysis [PDF]

91

 

 

C Mion, A SSlingeneyer, B Canaud, M Elie

 

 

       

Part III  -  DIALYSIS I

 

 

 

 

 

 

Prostacyclin prevents endothelial and platelet damage during dialysis [PDF]

111

 

 

J H Turney, N J Dodd, L C Williams, M J Weston

 

 

 

 

 

 

Evaluation of prostaglandib D2 (PGD2) as an anticoaugulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1) [PDF]

117

 

 

S Nakagawa, N Matsui, T Akiba, T Shinoda, Y Fukudome, K Ozawa, M Baba, T Nakanishi, J Takeuchi

 

 

       

Platelet microaggregates and release of endogenous prostacyclin during the initiak phase of haemodialysis [PDF]

122

 

 

Ch Leithner, H Sinzinger, K Silberbauer, H K Stummvoll

 

 

       

The effects of haemodialysis on cerebral blood flow [PDF]

126

 

 

H Holzer, K Marguc, H Pogglitsch, E Ott, H katschnig

 

 

       

Epidemiology of dialysis induced hypotension [PDF]

133

 

 

P Degoulet, I Reach, S Di Giulio, C Devries, J J Rouby, F Aimé, M Vonlanthem

 

 

       

Part IV –DIALYSIS 2

 

 

 

 

 

 

Haemodynamics of isolated versus dialytic ultrafiltration in the unanaesthetised, non-uraemic dog [PDF]

139

 

 

J T Daugirdas, W T Chen, T S Ing, R E vestal, S popli, J E hano, H K Jacobs

 

 

 

 

 

 

Long-term haemodialysis treatment with sodiaum removal by convention [PDF]

146

 

 

F Locatelli, L Pedrini, R Ponti, R Costanzo, S Di Filippo, P Marai, C Pozzi, G P Bonacina

 

 

       

Influence of dialysate composition on cardiovascular function in isovolaemic haemodialysis [PDF]

153

 

 

B Wehle, H Asaba, J castenfors, B Gunnarsson, J Bergstrom

 

 

       

Correlation between plasma sodium acetate concemtration and systemic vascular resistances [PDF]

160

 

 

D C Schohn, S Klein, Y Mitsuishi, H A Jahn

 

 

       

Part   V –DIALYSIS AND HAEMOFILTRATION

 

 

 

 

 

 

Improvement of hyperlipidaemia by bezafibrate treatment in RDT patients [PDF]

169

 

 

P Grutzmacher, E Scheuermann, W Lang

 

 

 

 

 

 

High efficiency haemofiltration (ultrafiltration of more than 250ml/min for two hours) in eigth uraemic patient [PDF]

176

 

 

G Dongradi, T Haas, F Villeboeuf, F Khazine, J P Fendler

 

 

 

 

 

 

Erythrocyte transport of middle molecular substances [PDF]

183

 

 

M Gajdos, V Spustova, M Gerukova, R Dzurik

 

 

 

 

 

 

Interferon production by leucocytes of dialysed chronic uraemic patients [PDF]

188

 

 

Gy Gal, M Toth, S Toth

 

 

 

 

 

 

Part   VI – PERITONEAL DIALYSIS

 

 

 

 

 

 

Nutritional behaviour of patients on continuous ambulatory peritoneal dialysis [PDF]

193

 

 

H v Baeyer, G M Gahl, H Riedinger, B Borowzak, M Kessel

 

 

 

 

 

 

Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis [PDF]

199

 

  C Verger, O Brunschvicg, Y Le Charpentier, A Lavergne, J Vantelon    
        

Intraperitoneal administration of insulin during peritoneal dialysis of diabetic patients with terminal renal failure [PDF]

206

 

 

K E Hemmeloff Andersen, P Hyltoft Petersen

 

 

 

 

 

 

Peritonitis, a frequently lethal complication of intermittent and continuous ambulatory peritoneal dialysis [PDF]

212
 

 

A Slingeneyer, C Mion, J J Beraud, R Oules, B Branger, M Balmes    
       

Renal transplantation in patients on continuous ambulatory peritoneal dialysis [PDF]

222
 

 

R Gokal, J M Ramos, P Veitch, G Proud, R M R Taylor, M K Ward, R Wilkinson, D N S Kerr    
       

PART VII – GUEST LECTURE

 

 

 

 

 

 

Hepatitis B in haemodialysis: vaccination against HBS antigen [PDF]

231

 

 

J Crosnier

 

 

 

 

 

 

PART VIII – SYMPOSIUM

 

 

 

 

 

 

How to prevent vascular instability: haemofiltration [PDF]

243

 

 

E Quellhorst, B Schuenemann, U Hildebrand

 

 

 

 

 

 

Role of small molecule removal in the control of treatment morbidity with haemodialysis and haemofiltration [PDF]

249

 

 

S Shaldon

 

 

 

 

 

 

The role of sodium in the prevention of vascular instability during haemodialysis [PDF]

255

 

 

N K Man, S Di Giulio, J Zingraff, A Sausse, J L Funk-Brentano

 

 

 

 

 

 

PART IX – POSTERS ON DIALYSIS AND RELATED TOPICS

 

 

 

 

 

 

Heparin is unable to prevent contact activation by three different membranes [PDF]

269

 

  P Stratta, C Canavese, G Mangiarotti, A pacitti, C Tetta, R Coppo, R Ragni, A Vercellone

 

 

 

 

 

 

Prophylaxis of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) by a simple micribiological patient self-check [PDF]

275

 

 

K Zaruba, M Olivieri

 

 

 

 

 

 

Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment [PDF]

280

 

 

J P Arends, R T Krediet, E W Boeshoten, J van der Lalie, C H N veenhos, A E G Kr von dem Borne

 

 

 

 

 

 

Changes in red cell mass, plasma volume and haematocrit in patients on continuous ambulatory peritoneal dialysis [PDF]

286

 

 

M de Paepe, N Lameire, K Schelstraete, S Ringoir

 

 

 

 

 

 

Evaluation of 25(OH)D loss in dilysate of children on contunuous ambulatory peritoneal dialysis [PDF]

290

 

 

M Guillot, C Lavocat, M Garabedian, C Sachs, S Balsan, M G Gagnadouz, M Broyer

 

 

 

 

 

 

Economic preparation of sterile pyrogen free infusate for haemofiltration [PDF]

293

 

 

P Ramperez, M C Beau, G Deschdt, J L Flavier, L Nilsson, C Mion, S Shaldon

 

 

       

A double chamber catheter for chronic ambulatory peritoneal dialysis (CAPD) [PDF]

297

 

 

V Calderaro, B Memoli, V terracciano, M M Balletta, R Genualdo, S Riccardi, F Fabiani, E Di Salvo, V E Andreucci

 

 

       

Complement activation and Clq binding activity in haemodialysis [PDF]

300

 

 

N J Dodd, D vergani, J H Turney, V Parsons, M J Weston

 

 

       

Transvenous serial Xero-arteriography: a new non-invasive angioghraphic method for av-fistulas in haemodialysis patients [PDF]

305

 

 

K Konner, H M Karnahl

 

 

       

PART X – SYMPOSIUM

 

 

 

 

 

Transplantation in children: technical aspects, drug therapy and problems related to primary renal disease [PDF]

313

 

 

M Broyer, M F Gagnadoux, D Beurton, B Pascal, J Louville

 

 

       

Renal transplantation in children [PDF]

321

 

 

R N Fine

 

 

       

Growth and rehabilitation of long-term survivors of treatment for end-stage renal failure in childhood [PDF]

329

 

 

C Chantler, M Broyer, R A Donckerwolcke, H Brynger, F P Brunner, C Jacobs, P Kramer, N H Selwood, A J Wing

 

 

       
PART XI – GUEST LECTURE    
     

Induction of specific unresponsiveness in kidney transplant recipients [PDF]

345

 

 

J R Batchelor, R I Lechler

 

 

     

PART XII – TRANSPLANTATION I

 

 

 

 

 

Pretransplant blood transfusions can harm matched kidneys in dogs

[PDF]

351

 

 

A B Bijnen, H Obertop, G J C M Niessen, J Jeekel, D L Westbroek

 

 

 

 

 

Altered immunoregolatory function in long-term renal allograft recipients [PDF]

357

 

 

R D Guttmann, R S Poulsen

 

 

 

 

 

Early evaluation of Ia monoclonal antibodies in prolonging non-human primate skin allograft survival [PDF]

362

 

 

S N Chatterjee, R Billings, D Bernoco, P Terasaki

 

 

     

Are transplantation antigens stable constituents on human renal allografts? [PDF]

367

 

 

P Hayry, Eeva von Willebrand, J Ahonen, B E Eklund

 

 

     

Platelet abnormalities in renal transplantation [PDF]

375

 

 

A Capitano, C Ponticelli, A D'Angelo, P M Mannucci

 

 

     

Pathogenic approach th the hypophasphataemia of renal transplantation [PDF]

380

 

 

JJ Plaza, J M Castrillo, V Alvarez, A Rapado, L Hernado

 

 

     

Cell-mediated immunity during RDT and the outcome of transplantation [PDF]

387

 

 

M A Watson, D N H Hamilton, J D Briggs, S G Macpherson, D Tsakiris

 

 

     
PART XIII – TRANSPLANTATION 2    

 

 

 

Controlled trial of low versus high dose oral steroid therapy in 100 cadaveric renal transplantation [PDF]

394

 

 

J A C Buckels, P Mackintosh, A D Barnes

 

 

 

 

 

Nephrotoxicity and metabolic acidosis in transplant patients on Cyclosporin A [PDF]

400

 

 

D V Hamilton, D B Evans, R G henderson, S Thiru, R Y Calne, D J G White, D J S carminchael

 

 

     

Experimental normothermic kidney preservation: histological considerations [PDF]

410

 

 

R N Dunn, F K Merkel, D Roseman, H Haklin, K English

 

 

     

A comparison of two approaches to the problem of early acute rejection of renal transplants [PDF]

416

 

 

B D Pentlow, M Cooper, R Goffin, P harrison, A S Parker, C Mackenzie, H White

 

 

     

Immunosuppressive effect of bredinin in the management of patients with renal transplantation [PDF]

420

 

 

R Kusaba, O Otubo, H Sugimoto, I Takahashi, Y Yamada, J Yamauchi, N Akiyama, T Inou

 

 

       
PART XIV – TRANSPLANTATION 3    
     

Induction of specific transplantation tolerance via immunisation with donor-directed idiotype(s) [PDF]

426

 

 

P Hayry, Anu Soots, A Nemlander, H Binz, E Weight, M fenner, H Wigzell

 

 

     

MLR inhibitory activity of pretrasplant anti-donor B cell antibodies, and kidney graft survival [PDF]

433

 

 

V Lenhard, H Diehm, W Rettwitz, K Dreikorn

 

 

     

Should the upper age limit for cadaveric kidney donors be changed? [PDF]

439

 

 

J A van der Vliet, G G Persijn, G Kootstra

 

 

     

Beneficial influence of matching for D/DR antigens and treatment with cyclosporin-A on kidney graft survival in transfused thesus monkeys [PDF]

446

 

 

J CC Borieffs, R L Marquet, P Neuhaus

 

 

     

Suppressor cell activity in human renal allograft recipients [PDF]

454

 

 

C Hammer, W land, L A Castro

 

 

     
PART XV – POSTERS ON TRANSPLANTATION    
     

Rejection encephalopathy

[PDF]

461

 

 

M L P Gross, R pearson, P Sweny, O N fernando, J F Moorhead

 

 

     

Effects pf blood transfusion on cellular immunity

[PDF]

465

 

 

F Gioacchino, P belardi, R Coppo, F Quarello, S Alloatti, M Pozzato, G Giraudo, D Roccatello, B basolo, R Boero, G Piccoli

 

 

     

Transplantation of cadaveric paediatric donor kidneys into adult recipients [PDF]

469

 

 

G D Kremer, M J H Slooff, A M Tegzess, S Meijer

 

 

     

Enhanced renal allograft survival from azathioprine/steroid modified antibody-dependent cellular cytotoxicity [PDF]

475

 

 

Lynette J Dumble, Ileene M Macdonald, Priscilla Kincaid-Smith. G J A Clunie

 

 

     

In vitro immunoresponsiveness in recipients of cadaveric renal allografts during ARG therapy [PDF]

481

 

 

H Grosse-Wilde, H D Jakubowski, F W Eigler, E K Kuwert

 

 

     

Suppressor cells in kidney allograft tolerance [PDF]

486

 

 

B Charpentier, P Lang, B Martin, D Fries

 

 

     
PART XVI – NEPHROLOGY I    
     

Treatment of idiopathic acute crescentic glomerulonehritis by immunodepression and plasma-exchanges. A prospectives randomised study [PDF]

493

 

 

G Rifle, J M Chalopin, P Zech, P Deteix, F Ducret, P Vialtel, D Cordonnier

 

 

     

Long term study of mesangial proliferative glomerulonephritis with IgM deposits [PDF]

503

 

 

A Vangelista, G frascà, G biagini, V Bonomini

 

 

     

Glomerular haemodynamics in pregnant rats

[PDF]

508

 

 

A Dal Canton, G Conte, C Esposito, G Fuiano, R Guasco, D Russo, M Sabbatini, F Uccello, V E Andreucci

 

 

     

Renal prostaglandins E2 and F2α in normal pregnancy and in pregnancy with hypertension

[PDF]

512

 

 

S Kovatz, M Rathaus, N ben Aderet, J Bernheim

 

 

     
PART XVII – NEPHROLOGY 2: PAEDITRIC NEPHROLOGY    
     

Changes in dental development in paediatric patients with chronic kidney disease

[PDF]

517

 

 

A Bubblitz, E machat, K Scharer, G Komposch, O Mehls

 

 

     

Body iron stores in children with chronic renal failure in relation to HLA phenotypes

[PDF]

524

 

 

D E Muller-Wiefel, V Lenhard, K Scharer

 

 

     

Acute renal failure in 11 children with non-Hodgkin lymphoma

[PDF]

531

 

 

L Radaelli, F Fossati-Bellani, M Gasparini, S Bertoli, C Gianni, G barbiano di Belgiojoso, G Colussi

 

 

     

Microsurgery for haemodialysis distal arteriovenus fistulae in children weighting less than 10Kg

[PDF]

537

 

 

P Bourquelot, L Wolfeler, L Lamy

 

 

     

Hypertrophic cardiomyophathy in children with end-stage renal disease and hypertension

[PDF]

542

 

 

A Drukker, J urbach, J Glaser

 

 

     
PART XVIII – NEPHROLOGY 3    
     

Tumor-like growth of parathyroid autografts in uraemic patients

[PDF]

548

 

 

U Frei, I Klempa, M Schneider, E H Scheuermann, K M Koch

 

 

     

Mechanism of allopurinol action in calcium oxalate stone formers

[PDF]

556

 

 

B Tomlinson, A Al-khader, S L Cohen, G P kasidas, S Krywawych, L Edgar, G A Rose

 

 

     

Possible role of inorganic sulphate in the pathogenesis of hyperparathyroidism in chronic renal failure

[PDF]

561

 

 

D Michalk, W Tschope, H J Bohles, O Mehis

 

 

       

Osteopenia during long-term haemodialysis. response to vitamin D3 analogues

[PDF]

567

 

 

N Muirhead, S Adamin, R A Fraser, G R D Catto, N Edward, J L H O'Riordan

 

 

       

The effects of vitamin A toxicity on calcium and lipid metabolism in chronic renal failure

[PDF]

573

 

 

P Miller, P Sweny, J W Persaud, Z Varghese, K Farrington, M K Chan, R A Baillord, J F Moorhead

 

 

       
PART XIX –NEPHROLOGY 4    
       

The influence of 1 alpha-hydroxycholecalciferol on left ventricular function in end-stage renal failure

[PDF]

579

 

 

R J S McGonigle, A D Timmis, J Keenan, D E Jewitt, M J Weston, V Parsons

 

 

       

Postsneptic adrenergic unresponsiveness in hypotensive haemodialysis patients

[PDF]

586

 

 

A Botey, J Gaya, J Montoliu, A Torras, F Rivera, J Lòpez-Pedret, L Revert

 

 

       

Effect of extracorporeal blood cooling on dialytic arterial hypotension

[PDF]

597

 

 

Q Maggiore, F Pizzarelli, C Zoccali, S Sisca, F Nicolò, S Parlongo

 

 

       

Effect of captopril on the systemic and renal responses to acute isotonic volume expansion in normal man

[PDF]

603

 

 

A Mimran, J Ribstein

 

 

       

The role of the adrenergetic system in hypertension after renal tranplantation

[PDF]

608

 

 

R S Smith, J L reid, D J Warren

 

 

       
       
PART XX – GUEST LECTURE    
     

The endocrine system in patients with acute renal failure transplantation

[PDF]

617

 

 

F Kokot

 

 

       
PART XXI – POSTERS ON NEPHROLOGY    
       

Peripheral haematocrit modulates erythropoietin production and kinetics of reticulocytes in chronic uraemic patients [PDF]

633

 

 

A Walle, J F Garcia, W Niedermayer

 

 

       

Urea Cycle and protein content in leucocytes from normal persons and uraemics

[PDF]

638

 

 

M Vlaho, H-G Sieberth

 

 

       

Blockers of beta and H2 receptors and secondary hyperparathyroidism of uraemia

[PDF]

642

 

 

R Makdassi, P H Decourcelle, Ph Moriniere, B Coevoet, J F de Fremont, J Kassouf, A Roussel, J D Gheerbrand, M Andrejak, A Fournier

 

 

       

Predictive value of 99mTc pyrophosphate bone scintigraphy for vitamin D trials in uraemia

[PDF]

648

 

 

J L Vanherweghem, M Dhaene, C Tielemans, M Dratwa, P Verbanck, P Bergmann, A Schoutens, M Fuss

 

 

       

Neurophysiological abnormalities in uraemic encephalophaty

[PDF]

652

 

 

A Albertazzi, B Di Paolo, G del Grosso, D Gambi, P M Rossini

 

 

       

Chairman's introductory talk

[PDF]

661

 

 

J P Merrill

 

 

       

Dialysis strategy: cost and effectiveness

[PDF]

664

 

 

D N S Kerr

 

 

       

Desferrioxamine-induced changes of aluminium kinetics during haemodialysis

[PDF]

674

 

 

H Graf, H K Stummvoll, Vanee Meisinger

 

 

       

Vascular stability and middle molecules removal in hypeertonic haemodiafiltration

[PDF]

681

 

 

V Cambi, C Buzio, L Arisi, C Calderini, S David, A Manari, F Bono, P Zanelli

 

 

       

An interactive graphic database microcomputer for clinical control in data intensive therapies

[PDF]

690

 

 

M Gordon, H E de Wardener, C Venn, J T Webb, H Adams

 

 

       

Assessing the adequacy of dialysis

[PDF]

697

 

 

P E Teschan, H E Ginn, J R Bourne, J W Ward

 

 

 

 

 

     
PART XXIII - JOINT MEETING EDTA/ISAO - SESSION 2    
       

Chairman's Introductory talk

[PDF]

706

 

 

J Hamburger

 

 

       

Bionics in spare parts medicine: management and clinical issues

[PDF]

708

 

 

P Galleti

 

 

       

Malignant tumors in dialysis patients: a nationwide survey

[PDF]

724

 

 

K Ota, N Yamashita, T Suzuki, T Agishi

 

 

       

Silicone filings in microphages of viscers. an iatrogenic complication of haemodialysis

[PDF]

731

 

 

J Bommer, R Waldherr, E Ritz

 

 

       

Effect of plasma exchange and thoracic duct drainange on immunological status in glomerulonephritis

[PDF]

736

 

 

V Bonomini, A Vangelista, S Stefoni, G Frascà, A Nanni Costa

 

 

       

Continuous arteriovenus haemofiltration. A new kidney replacement therapy

[PDF]

743

 

 

P Kramer, J Schrader, W Bohnsack, G Grieben, H J Grone, F Scheler

 

 

       
     
Author Index [PDF]
770
 

 

In order to open the above PDF files you need Acrobat Reader.

If you do not have it, you can download it here